Search - tctmd.com

Displaying 361 - 380 of 667

Sort: Relevancy | Date

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

News Daily News

LV Flow After TAVR Predicts Late Mortality

June 11, 2015

News Daily News

El Flujo VI Post-TAVR Predice la Mortalidad Tardía

June 11, 2015

Presentation TVT 2015

New Transfemoral Access Closure Devices

Presenter: Eberhard Grube

June 05, 2015

Presentation TVT 2015

Avoiding and Managing Transfemoral Vascular Complications

Presenter: Augusto D. Pichard

June 05, 2015

Presentation TVT 2015

An Interventionalists Perspective: Will the HEART TEAM Change With a Default Transfemoral TAVR Strategy for Most Patients?

Presenter: Nicolo Piazza

June 04, 2015

Presentation TVT 2015

A Surgeons Perspective: Will the IMPLANTING TEAM Change for Intermediate- and Low-Risk Transfemoral TAVR Patients?

Presenter: Francesco Maisano

June 04, 2015

Presentation TVT 2015

The North American 3M TAVR Study: Evaluating the Efficacy, Feasibility, and Safety of Next-Day Discharge Home in Patients Undergoing Elective Transfemoral TAVR

Presenter: David A. Wood

June 04, 2015

Presentation TVT 2015

Direct Aortic vs Subclavian-Axillary TAVR: Lessons From the CoreValve Pivotal Trial

Presenter: Raj Makkar, Mathew Williams, Thomas G. Gleason

June 04, 2015

Presentation TVT 2015

Transapical vs Direct Aortic TAVR: Lessons From the PARTNER Trial

Presenter: Raj Makkar, Mathew Williams, Vasilis Babaliaros

June 04, 2015

Presentation TVT 2015

Transcaval TAVR: Technique, Rationale, and Complications

Presenter: Raj Makkar, Mathew Williams, Adam B. Greenbaum

June 04, 2015

Presentation TVT 2015

Subclavian-Axillary TAVR: Optimal Technique and Complication Management

Presenter: Raj Makkar, Mathew Williams, A. Pieter Kappetein

June 04, 2015

Presentation TVT 2015

Direct Aortic TAVR: Optimal Technique and Complication Management

Presenter: Raj Makkar, Mathew Williams, Michael J. Reardon

June 04, 2015

Presentation TVT 2015

Transapical TAVR: Optimal Technique and Complication Management

Presenter: Raj Makkar, Mathew Williams, Thomas Walther

June 04, 2015

Presentation TVT 2015

Be Prepared! Management of Major Vascular Complications

Presenter: Raj Makkar, Mathew Williams

June 04, 2015

Presentation TVT 2015

Percutaneous Closure Technique: Step by Step

Presenter: Raj Makkar, Mathew Williams, Philippe Genereux

June 04, 2015

Presentation TVT 2015

What Is the Optimal Vascular Access Screening Method? Now and in the Future

Presenter: Raj Makkar, Mathew Williams, Hemal Gada

June 04, 2015

Presentation TVT 2015

Are Transfemoral TAVR Access Site Complications Decreasing?

Presenter: Raj Makkar, Mathew Williams

June 04, 2015

News Daily News

Un Registro Belga Confirma una Supervivencia Similar a los 3 Años con las Válvulas Sapien y CoreValve en la realización de TAVR Transfemorales

Yael L. Maxwell

June 03, 2015

News Daily News

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Yael L. Maxwell

June 03, 2015

Advertisement

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

LV Flow After TAVR Predicts Late Mortality

El Flujo VI Post-TAVR Predice la Mortalidad Tardía

New Transfemoral Access Closure Devices

Avoiding and Managing Transfemoral Vascular Complications

An Interventionalists Perspective: Will the HEART TEAM Change With a Default Transfemoral TAVR Strategy for Most Patients?

A Surgeons Perspective: Will the IMPLANTING TEAM Change for Intermediate- and Low-Risk Transfemoral TAVR Patients?

The North American 3M TAVR Study: Evaluating the Efficacy, Feasibility, and Safety of Next-Day Discharge Home in Patients Undergoing Elective Transfemoral TAVR

Direct Aortic vs Subclavian-Axillary TAVR: Lessons From the CoreValve Pivotal Trial

Transapical vs Direct Aortic TAVR: Lessons From the PARTNER Trial

Transcaval TAVR: Technique, Rationale, and Complications

Subclavian-Axillary TAVR: Optimal Technique and Complication Management

Direct Aortic TAVR: Optimal Technique and Complication Management

Transapical TAVR: Optimal Technique and Complication Management

Be Prepared! Management of Major Vascular Complications

Percutaneous Closure Technique: Step by Step

What Is the Optimal Vascular Access Screening Method? Now and in the Future

Are Transfemoral TAVR Access Site Complications Decreasing?

Un Registro Belga Confirma una Supervivencia Similar a los 3 Años con las Válvulas Sapien y CoreValve en la realización de TAVR Transfemorales

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content